Work

Omalizumab Plus House Dust Mite Immunotherapy for Asthma: A Randomised, 5‐Arm, Non‐Blinded, Non‐Placebo‐Controlled, Multicentre, Interventional Trial

Year: 2025

Type: article

Source: Clinical & Experimental Allergy

DOI: 10.1111/cea.70021

Authors: Andrzej Bożek, Alicja Grzanka, Giorgio W. Canonica

Institutions: Medical University of Silesia, Humanitas University, IRCCS Humanitas Research Hospital

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Stallergenes Greer France

OpenAlex ID: W4407868557

FWCI:

Cites: 10

Cited by:

Related to: 10